Offer - Urjas Oil for just ₹ 1
Leunase 5000 IU Injection, a prescription drug, is manufactured in various forms such as Injection. Primarily, it is used for the treatment of Blood Cancer.
The correct dosage of Leunase 5000 IU Injection depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Leunase 5000 IU Injection also has some side effects, the most common being Rash, Nausea or vomiting, Increased Liver Enzymes. Such side effects of Leunase 5000 IU Injection normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Leunase 5000 IU Injection is Moderate for pregnant women and Severe for women who are breastfeeding. Warnings related to Leunase 5000 IU Injection's effects on the liver, heart and kidney, if any, have been listed below.
Leunase 5000 IU Injection is contraindicated in people with pre-existing medical conditions like Bleeding, Pancreatitis as it can result in adverse effects. Other conditions have been mentioned below in the Leunase 5000 IU Injection contraindications section.
Additionally, Leunase 5000 IU Injection may also adversely react with other medicines. Refer to the list below for further details.
In addition to the above precautions for Leunase 5000 IU Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Leunase 5000 IU Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Leunase 5000 IU Injection safe for pregnant women?
Leunase can have harmful effects in pregnant women. If you experience any discomfort after using Leunase, then discontinue the use and take your doctor's advice.
Is the use of Leunase 5000 IU Injection safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Leunase. So it is adviced to consult the doctor before using it.
What is the effect of Leunase 5000 IU Injection on the Kidneys?
Very few cases of side effects of Leunase on kidney have been reported.
What is the effect of Leunase 5000 IU Injection on the Liver?
Leunase may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Leunase 5000 IU Injection on the Heart?
Using Leunase does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Leunase 5000 IU Injection unless your doctor advises you to do so -
Is this Leunase 5000 IU Injection habit forming or addictive?
No, you will not get addicted to Leunase 5000 IU Injection.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Leunase 5000 IU Injection as you may feel sleepy.
Is it safe?
Yes, but consume Leunase 5000 IU Injection only on doctor's advice.
Is it able to treat mental disorders?
No, Leunase 5000 IU Injection is not used to treat mental disorders.
Interaction between Food and Leunase 5000 IU Injection
You can take Leunase 5000 IU Injection with food.
Interaction between Alcohol and Leunase 5000 IU Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Leunase 5000 IU Injection.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Elspar® (Asparaginase)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 868-869
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 190-191